Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Differentiating compensatory mechanisms associated with low tolerance to central hypovolemia in women.

Schlotman TE, Akers KS, Nessen SC, Convertino VA.

Am J Physiol Heart Circ Physiol. 2019 Mar 1;316(3):H609-H616. doi: 10.1152/ajpheart.00420.2018. Epub 2018 Dec 28.

PMID:
30592899
2.

Recurrent bacteremia: A 10-year retrospective study in combat-related burn casualties.

Aurora A, Le TD, Akers KS, Blyth DM, Graybill JC, Clemens MS, Chung KK, Rizzo JA.

Burns. 2019 May;45(3):579-588. doi: 10.1016/j.burns.2018.10.003. Epub 2018 Oct 29.

PMID:
30385059
3.

Rapid degradation and non-selectivity of Dakin's solution prevents effectiveness in contaminated musculoskeletal wound models.

Mangum LC, Franklin NA, Garcia GR, Akers KS, Wenke JC.

Injury. 2018 Oct;49(10):1763-1773. doi: 10.1016/j.injury.2018.08.004. Epub 2018 Aug 6.

4.

A 12-Year Analysis of Nonbattle Injury Among US Service Members Deployed to Iraq and Afghanistan.

Le TD, Gurney JM, Nnamani NS, Gross KR, Chung KK, Stockinger ZT, Nessen SC, Pusateri AE, Akers KS.

JAMA Surg. 2018 Sep 1;153(9):800-807. doi: 10.1001/jamasurg.2018.1166.

5.

Unrealized potential of the US military battlefield trauma system: DOW rate is higher in Iraq and Afghanistan than in Vietnam, but CFR and KIA rate are lower.

Nessen SC, Gurney J, Rasmussen TE, Cap AP, Mann-Salinas E, Le TD, Shackelford S, Remick KN, Akers KS, Eastridge BJ, Jenkins D, Stockinger ZT, Murray CK, Gross KR, Seery J, Mabry R, Holcomb JB.

J Trauma Acute Care Surg. 2018 Jul;85(1S Suppl 2):S4-S12. doi: 10.1097/TA.0000000000001969.

PMID:
29787556
6.

Thermal stability of mafenide and amphotericin B topical solution.

Rizzo JA, Martini AK, Pruskowski KA, Rowan MP, Niece KL, Akers KS.

Burns. 2018 Mar;44(2):475-480. doi: 10.1016/j.burns.2017.08.019. Epub 2017 Sep 19.

PMID:
28935221
7.

Utility of the Nanosphere Verigene in the Identification of Bacteremia Isolates From the Burn Intensive Care Unit.

Farmer A, Lanteri CA, Steele E, Mende K, Pamplin J, Akers KS.

Mil Med. 2017 Sep;182(9):e1779-e1784. doi: 10.7205/MILMED-D-17-00018.

PMID:
28885937
8.

Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.

Shiels SM, Tennent DJ, Akers KS, Wenke JC.

Injury. 2017 Oct;48(10):2095-2100. doi: 10.1016/j.injury.2017.08.021. Epub 2017 Aug 16.

PMID:
28842287
9.

Wound Penetration of Cefazolin, Ciprofloxacin, Piperacillin, Tazobactam, and Vancomycin During Negative Pressure Wound Therapy.

Rowan MP, Niece KL, Rizzo JA, Akers KS.

Adv Wound Care (New Rochelle). 2017 Feb 1;6(2):55-62. doi: 10.1089/wound.2016.0698.

10.

Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.

Cardile AP, Woodbury RL, Sanchez CJ Jr, Becerra SC, Garcia RA, Mende K, Wenke JC, Akers KS.

Adv Exp Med Biol. 2017;973:53-70. doi: 10.1007/5584_2016_93.

11.

Initial Characterization of the Pig Skin Bacteriome and Its Effect on In Vitro Models of Wound Healing.

McIntyre MK, Peacock TJ, Akers KS, Burmeister DM.

PLoS One. 2016 Nov 8;11(11):e0166176. doi: 10.1371/journal.pone.0166176. eCollection 2016.

12.

In Vitro activity of Manuka Honey and polyhexamethylene biguanide on filamentous fungi and toxicity to human cell lines.

Yabes JM, White BK, Murray CK, Sanchez CJ, Mende K, Beckius ML, Zera WC, Wenke JC, Akers KS.

Med Mycol. 2017 Apr 1;55(3):334-343. doi: 10.1093/mmy/myw070.

13.

Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.

Cota JM, FakhriRavari A, Rowan MP, Chung KK, Murray CK, Akers KS.

Clin Ther. 2016 Sep;38(9):2016-31. doi: 10.1016/j.clinthera.2016.08.001. Epub 2016 Aug 30. Review.

PMID:
27586127
14.

The use of PCR/Electrospray Ionization-Time-of-Flight-Mass Spectrometry (PCR/ESI-TOF-MS) to detect bacterial and fungal colonization in healthy military service members.

Vetor R, Murray CK, Mende K, Melton-Kreft R, Akers KS, Wenke J, Spirk T, Guymon C, Zera W, Beckius ML, Schnaubelt ER, Ehrlich G, Vento TJ.

BMC Infect Dis. 2016 Jul 22;16:338. doi: 10.1186/s12879-016-1651-7.

15.

Time-Dependent Effectiveness of Locally Applied Vancomycin Powder in a Contaminated Traumatic Orthopaedic Wound Model.

Tennent DJ, Shiels SM, Sanchez CJ Jr, Niece KL, Akers KS, Stinner DJ, Wenke JC.

J Orthop Trauma. 2016 Oct;30(10):531-7. doi: 10.1097/BOT.0000000000000617.

PMID:
27124826
16.

Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates.

Chang D, Garcia RA, Akers KS, Mende K, Murray CK, Wenke JC, Sanchez CJ.

Pharmaceuticals (Basel). 2016 Mar 17;9(1). pii: E16. doi: 10.3390/ph9010016.

17.

Antimicrobial resistance acquisition after international travel in U.S. travelers.

Blyth DM, Mende K, Maranich AM, Beckius ML, Harnisch KA, Rosemann CA, Zera WC, Murray CK, Akers KS.

Trop Dis Travel Med Vaccines. 2016 Mar 14;2:4. doi: 10.1186/s40794-016-0020-2. eCollection 2016.

18.

Voriconazole Enhances the Osteogenic Activity of Human Osteoblasts In Vitro through a Fluoride-Independent Mechanism.

Allen KC, Sanchez CJ Jr, Niece KL, Wenke JC, Akers KS.

Antimicrob Agents Chemother. 2015 Dec;59(12):7205-13. doi: 10.1128/AAC.00872-15. Epub 2015 Aug 31.

19.

Microbial Contamination of Enteral Nutrition Mixtures in a Hyperthermal Environment: A Follow-Up Investigation.

Akers KS, Shields BA, Akers ME, Mende K, Beckius ML, Murray CK, Chung KK.

Nutr Clin Pract. 2015 Aug;30(4):582-4. doi: 10.1177/0884533615586203. No abstract available.

PMID:
26206953
20.

In vitro study of the variable effects of proton pump inhibitors on voriconazole.

Niece KL, Boyd NK, Akers KS.

Antimicrob Agents Chemother. 2015 Sep;59(9):5548-54. doi: 10.1128/AAC.00884-15. Epub 2015 Jun 29.

21.

Preliminary method for direct quantification of colistin methanesulfonate by attenuated total reflectance Fourier transform infrared spectroscopy.

Niece KL, Akers KS.

Antimicrob Agents Chemother. 2015 Sep;59(9):5542-7. doi: 10.1128/AAC.00805-15. Epub 2015 Jun 29.

22.

Bacterial Contamination of Burn Unit Employee Identity Cards.

Caldwell NW, Guymon CH, Aden JK, Akers KS, Mann-Salinas EA.

J Burn Care Res. 2016 Sep-Oct;37(5):e470-5. doi: 10.1097/BCR.0000000000000254.

PMID:
26056757
23.

Clinical infectious outcomes associated with biofilm-related bacterial infections: a retrospective chart review.

Barsoumian AE, Mende K, Sanchez CJ Jr, Beckius ML, Wenke JC, Murray CK, Akers KS.

BMC Infect Dis. 2015 Jun 7;15:223. doi: 10.1186/s12879-015-0972-2.

24.

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.

Akers KS, Rowan MP, Niece KL, Graybill JC, Mende K, Chung KK, Murray CK.

BMC Infect Dis. 2015 Apr 15;15:184. doi: 10.1186/s12879-015-0918-8.

25.

In vitro activity of Melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells.

Homeyer DC, Sanchez CJ, Mende K, Beckius ML, Murray CK, Wenke JC, Akers KS.

Med Mycol. 2015 Apr;53(3):285-94. doi: 10.1093/mmy/myu072. Epub 2015 Jan 28.

PMID:
25631479
26.

Pathogens present in acute mangled extremities from Afghanistan and subsequent pathogen recovery.

Wallum TE, Yun HC, Rini EA, Carter K, Guymon CH, Akers KS, Tyner SD, White CE, Murray CK.

Mil Med. 2015 Jan;180(1):97-103. doi: 10.7205/MILMED-D-14-00301.

PMID:
25562864
27.

Comparison of Decontamination Methods for Human Skin Grafts.

Mann-Salinas EA, Joyner DD, Guymon CH, Ward CL, Rathbone CR, Jones JA, Akers KS.

J Burn Care Res. 2015 Nov-Dec;36(6):636-40. doi: 10.1097/BCR.0000000000000188.

PMID:
25383978
28.

Biofilm formation by clinical isolates and its relevance to clinical infections.

Akers KS, Cardile AP, Wenke JC, Murray CK.

Adv Exp Med Biol. 2015;830:1-28. doi: 10.1007/978-3-319-11038-7_1. Review.

PMID:
25366218
29.

Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.

Akers KS, Rowan MP, Niece KL, Stewart IJ, Mende K, Cota JM, Murray CK, Chung KK.

Antimicrob Agents Chemother. 2015 Jan;59(1):46-52. doi: 10.1128/AAC.03783-14. Epub 2014 Oct 13.

30.

Dakin solution alters macrophage viability and function.

Cardile AP, Sanchez CJ Jr, Hardy SK, Romano DR, Hurtgen BJ, Wenke JC, Murray CK, Akers KS.

J Surg Res. 2014 Dec;192(2):692-9. doi: 10.1016/j.jss.2014.07.019. Epub 2014 Jul 18.

PMID:
25130774
31.

Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro.

Cardile AP, Sanchez CJ Jr, Samberg ME, Romano DR, Hardy SK, Wenke JC, Murray CK, Akers KS.

BMC Res Notes. 2014 Jul 17;7:457. doi: 10.1186/1756-0500-7-457.

32.

D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.

Sanchez CJ Jr, Akers KS, Romano DR, Woodbury RL, Hardy SK, Murray CK, Wenke JC.

Antimicrob Agents Chemother. 2014 Aug;58(8):4353-61. doi: 10.1128/AAC.02468-14. Epub 2014 May 19.

33.

Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.

Akers KS, Niece KL, Chung KK, Cannon JW, Cota JM, Murray CK.

J Trauma Acute Care Surg. 2014 Sep;77(3 Suppl 2):S163-70. doi: 10.1097/TA.0000000000000191.

PMID:
24770557
34.

Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis.

Akers KS, Mende K, Cheatle KA, Zera WC, Yu X, Beckius ML, Aggarwal D, Li P, Sanchez CJ, Wenke JC, Weintrob AC, Tribble DR, Murray CK; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

BMC Infect Dis. 2014 Apr 8;14:190. doi: 10.1186/1471-2334-14-190.

35.

Novel Pseudomonas fluorescens septic sacroiliitis in a healthy soldier.

Lindholm DA, Murray CK, Akers KS, O'Brien SD, Alderete JF, Vento TJ.

Mil Med. 2013 Aug;178(8):e963-6. doi: 10.7205/MILMED-D-13-00114.

PMID:
23929064
36.

Effects of local delivery of D-amino acids from biofilm-dispersive scaffolds on infection in contaminated rat segmental defects.

Sanchez CJ Jr, Prieto EM, Krueger CA, Zienkiewicz KJ, Romano DR, Ward CL, Akers KS, Guelcher SA, Wenke JC.

Biomaterials. 2013 Oct;34(30):7533-43. doi: 10.1016/j.biomaterials.2013.06.026. Epub 2013 Jul 5.

PMID:
23831189
37.

Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan.

Vento TJ, Cole DW, Mende K, Calvano TP, Rini EA, Tully CC, Zera WC, Guymon CH, Yu X, Cheatle KA, Akers KS, Beckius ML, Landrum ML, Murray CK.

BMC Infect Dis. 2013 Feb 5;13:68. doi: 10.1186/1471-2334-13-68.

38.

Biofilm formation by clinical isolates and the implications in chronic infections.

Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, Murray CK.

BMC Infect Dis. 2013 Jan 29;13:47. doi: 10.1186/1471-2334-13-47.

39.

Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumannii-calcoaceticus complex.

Barsoumian A, Calvano T, Markelz AE, Cassidy R, Murray CK, Beckius ML, Mende K, Akers KS.

Scand J Infect Dis. 2013 Jun;45(6):446-52. doi: 10.3109/00365548.2013.759270. Epub 2013 Jan 15.

PMID:
23317168
40.

In vitro toxicity and activity of Dakin's solution, mafenide acetate, and amphotericin B on filamentous fungi and human cells.

Barsoumian A, Sanchez CJ, Mende K, Tully CC, Beckius ML, Akers KS, Wenke JC, Murray CK.

J Orthop Trauma. 2013 Aug;27(8):428-36. doi: 10.1097/BOT.0b013e3182830bf9.

PMID:
23287750
41.

Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.

Akers KS, Cota JM, Chung KK, Renz EM, Mende K, Murray CK.

J Burn Care Res. 2012 Nov-Dec;33(6):e254-62. doi: 10.1097/BCR.0b013e31825042fa.

PMID:
22878490
42.

Effect of HMG-CoA reductase inhibitors on antimicrobial susceptibilities for gram-negative rods.

Farmer AR, Murray CK, Mende K, Akers KS, Zera WC, Beckius ML, Yun HC.

J Basic Microbiol. 2013 Apr;53(4):336-9. doi: 10.1002/jobm.201100614. Epub 2012 Jun 26.

PMID:
22736455
43.

Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration.

Akers KS, Cota JM, Frei CR, Chung KK, Mende K, Murray CK.

Antimicrob Agents Chemother. 2011 Oct;55(10):4639-42. doi: 10.1128/AAC.00374-11. Epub 2011 Aug 8.

44.

Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.

Markelz AE, Mende K, Murray CK, Yu X, Zera WC, Hospenthal DR, Beckius ML, Calvano T, Akers KS.

Antimicrob Agents Chemother. 2011 Oct;55(10):4707-11. doi: 10.1128/AAC.00112-11. Epub 2011 Aug 1. Erratum in: Antimicrob Agents Chemother. 2012 Feb;56(2):1149.

45.

Nontuberculous mycobacterium infection in a burn ICU patient.

Boyer JM, Blatz PJ, Akers KS, Okulicz JF, Chung KK, Renz EM, Hospenthal DR, Murray CK.

Burns. 2010 Nov;36(7):e136-9. doi: 10.1016/j.burns.2010.05.014. Epub 2010 Jul 1. No abstract available.

PMID:
20594758
46.

CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.

Akers KS, Barsoumian A, Beckius ML, Murray CK, Mende K.

Diagn Microbiol Infect Dis. 2010 Jun;67(2):209-11. doi: 10.1016/j.diagmicrobio.2010.02.004. No abstract available.

PMID:
20466197
47.

Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex.

Akers KS, Chaney C, Barsoumian A, Beckius M, Zera W, Yu X, Guymon C, Keen EF 3rd, Robinson BJ, Mende K, Murray CK.

J Clin Microbiol. 2010 Apr;48(4):1132-8. doi: 10.1128/JCM.02006-09. Epub 2010 Jan 27.

48.

Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital.

Akers KS, Mende K, Yun HC, Hospenthal DR, Beckius ML, Yu X, Murray CK.

Antimicrob Agents Chemother. 2009 Jun;53(6):2693-5. doi: 10.1128/AAC.01405-08. Epub 2009 Mar 23.

49.

A case of persistent Bacillus pumilis bacteremia associated with cholangitis.

Haymore BR, Akers KS, Ferguson TM.

J Infect. 2006 Feb;52(2):154-5. Epub 2005 Jun 29. No abstract available.

PMID:
15992931
50.

Structure-toxicity relationships for selected halogenated aliphatic chemicals.

Akers KS, Sinks GD, Schultz TW.

Environ Toxicol Pharmacol. 1999 Mar;7(1):33-9.

PMID:
21781907

Supplemental Content

Loading ...
Support Center